The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
Abstract
Objective: To investigate the safety and efficacy of etanercept in the treatment of uveitis associated with juvenile idiopathic arthritis (JIA). Methods: Children who met the American College of Rheumatology diagnostic criteria for JIA with active uveitis, who had anterior chamber cells of ≥1+ or requiring topical corticosteroid ≥3 times daily, and who were on a stable regimen for arthritis treatment were eligible. Study participants received etanercept (0.4 mg/kg) or placebo administered subcutaneously twice weekly for 6 months. All participants received open‐label etanercept for an additional 6 months. Results: Five patients received placebo and 7 received etanercept. Three of the 7 patients treated with etanercept and 2 of the 5 placebo‐treated patients were considered ophthalmic successes (P = 1.0). One patient in each treatment group was considered a treatment failure. Three of the 7 etanercept‐treated and 2 of the 5 placebo‐treated patients were neither successes nor failures by our definition. There were no serious adverse events for any patient during the entire study period. Reports of minor infections were comparable in each treatment group, 71% for etanercept and 60% for placebo (P = 0.58). Conclusion: In this small pilot study there was no apparent difference in the anterior segment inflammation between patients treated with etanercept and placebo. The stringent criteria used to measure ophthalmic success of treatment and the small patient population limit the implications of our findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A., Cawkwell, G. D., Silverman, E. D., Nocton, J. J., Stein, L. D., Gedalia, A., Ilowite, N. T., Wallace, C. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421103 · Cited by 1,246
Weiner, H. L. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.809 · Cited by 906
Giannini, E. H., Brewer, E. J., Kuzmina, N., Shaikov, A., Maximov, A., Vorontsov, I., Fink, C. W., Newman, A. J., Cassidy, J. T., & Zemel, L. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204163261602 · Cited by 588
A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis
Cassidy, J. T., Levinson, J. E., Bass, J. C., Baum, J., Brewer, E. J., Fink, C. W., Hanson, V., Jacobs, J. C., Masi, A. T., Schaller, J. G., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290216 · Cited by 425
Etanercept therapy in children with treatment-resistant uveitis
Reiff, A., Takei, S., Sadeghi, S., Stout, A., Shaham, B., Bernstein, B., Gallagher, K., & Stout, T. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1411::aid-art235>3.0.co;2-o · Cited by 298
Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis
Santos Lacomba, M., Marcos Martín, C., Gallardo Galera, J. M., Gómez Vidal, M. A., Collantes Estévez, E., Ramírez Chamond, R., & Omar, M. M. (2001) · Ophthalmic Research · doi:10.1159/000055677 · Cited by 296
Methotrexate therapy for chronic noninfectious uveitis
Samson, C. M., Waheed, N., Baltatzis, S., & Foster, C. S. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00576-0 · Cited by 250
Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate
Foster, C. S. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.437 · Cited by 213
Cited by
Ravelli, A., & Martini, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60363-8 · Cited by 1,993
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Levy-Clarke, G., Jabs, D. A., Read, R. W., Rosenbaum, J. T., Vitale, A., & Van Gelder, R. N. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.048 · Cited by 483
Juvenile Idiopathic Arthritis: Will Etanercept be an Improvement over Current Therapies?
De Benedetti, F., & Ravelli, A. (2000) · BioDrugs · doi:10.2165/00063030-200014020-00003 · Cited by 428
Do tumor necrosis factor inhibitors cause uveitis? A registry‐based study
Lim, L. L., Fraunfelder, F. W., & Rosenbaum, J. T. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22918 · Cited by 315
Suhler, E. B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.7.903 · Cited by 306
Self-citationRudwaleit, M., Rødevand, E., Holck, P., Vanhoof, J., Kron, M., Kary, S., & Kupper, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092585 · Cited by 297
Adalimumab in the therapy of uveitis in childhood
Biester, S., Deuter, C., Michels, H., Haefner, R., Kuemmerle-Deschner, J., Doycheva, D., & Zierhut, M. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.103721 · Cited by 294
Horneff, G., De Bock, F., Foeldvari, I., Girschick, H. J., Michels, H., Moebius, D., & Schmeling, H. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.087593 · Cited by 277
Pasadhika, S., & Rosenbaum, J. T. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.009 · Cited by 267
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Metadata
- Authors
- Smith, J. A., Thompson, D. J. S., Whitcup, S. M., Suhler, E., Clarke, G., Smith, S., Robinson, M., Kim, J., & Barron, K. S.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2005-02-04
- Volume
- 53
- Issue
- 1
- Pages
- 18-23
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1973730472
- Cited by
- 308
- References
- 20
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.